Will the Biotech sector sustain its momentum in 2024?

unlock icon  Upgrade Now

This premium article is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Upgrade Now See Benefits

or

Already have an account? Log in here.

Should You Invest $1,000 in iShares Biotechnology ETF Right Now?

Before you consider iShares Biotechnology ETF, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and iShares Biotechnology ETF wasn't on the list.

While iShares Biotechnology ETF currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Be Bigger Than Tesla, NVIDIA, and Google Cover

Could the next Tesla, NVIDIA, and Google be hiding in plain sight? Discover seven growth stocks with the potential to become tomorrow's market giants, fueled by breakthroughs in AI, nuclear energy, cybersecurity, and more.

Get This Free Report
Ryan Hasson
About The Author

Ryan Hasson

Contributing Author

Like this article? Share it with a colleague.

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Amgen (AMGN)
3.8942 of 5 stars
$435.52-0.8%2.31%18.79Hold$428.62
Gilead Sciences (GILD)
3.2041 of 5 stars
$166.33-0.1%1.97%N/AModerate Buy$171.63
Vertex Pharmaceuticals (VRTX)
3.5202 of 5 stars
$514.76-1.1%N/A30.28Moderate Buy$596.44
iShares Biotechnology ETF (IBB)N/A$199.54-2.1%0.17%N/AModerate Buy$199.54

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines